11 This illustrates a highly significant treatment effect of silodosin in terms of statistical significance compared with the placebo effect 11 and clinically meaningful symptom improvement. 15 In this post hoc analysis, silodosin on average improved each symptom score (except that for nocturia) by 21% to 38% over the baseline score.
← all excerpts
Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies.
1
—
—